| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.2741/3288 |
| P698 | PubMed publication ID | 19273110 |
| P50 | author | Michelle Glass | Q39685216 |
| Scott E. Graham | Q63769621 | ||
| P2093 | author name string | John Clive Ashton | |
| P921 | main subject | cannabinoid receptor | Q421237 |
| cannabinoids | Q422936 | ||
| CNR2 | Q17907844 | ||
| P304 | page(s) | 944-957 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Frontiers in Bioscience | Q5506062 |
| P1476 | title | Cannabinoid Receptors: A brief history and what not | |
| P478 | volume | 14 |
| Q82237362 | Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system |
| Q34028554 | Anti-aversive effects of cannabidiol on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a prey vs the wild snake Epicrates cenchria crassus confrontation paradigm |
| Q34898890 | Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress |
| Q34338079 | Cannabinoid CB1 Receptor Is Downregulated in Clear Cell Renal Cell Carcinoma |
| Q59291370 | Cannabinoid receptor type 2 (CB2)-selective N-aryl-oxadiazolyl-propionamides: synthesis, radiolabelling, molecular modelling and biological evaluation |
| Q45990546 | Corneal Nerve Fiber Structure, Its Role in Corneal Function, and Its Changes in Corneal Diseases. |
| Q37940938 | Doors of deception: the diaspora of designer drugs |
| Q34079507 | Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells |
| Q36679940 | Epigenetic Effects of Cannabis Exposure |
| Q52762339 | Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice. |
| Q35992150 | Highly selective inhibitors of monoacylglycerol lipase bearing a reactive group that is bioisosteric with endocannabinoid substrates |
| Q39508113 | Identification of a Potent and Selective Cannabinoid CB1 Receptor Antagonist from Auxarthron reticulatum. |
| Q37244823 | Immunoactive effects of cannabinoids: considerations for the therapeutic use of cannabinoid receptor agonists and antagonists |
| Q34173626 | Marijuana-based drugs: innovative therapeutics or designer drugs of abuse? |
| Q34413054 | Methods for recombinant expression and functional characterization of human cannabinoid receptor CB2. |
| Q41971391 | O-hydroxyacetamide carbamates as a highly potent and selective class of endocannabinoid hydrolase inhibitors |
| Q41956563 | Peripheral interactions between cannabinoid and opioid systems contribute to the antinociceptive effect of crotalphine |
| Q35005640 | Pharmacogenetics of new analgesics |
| Q38458891 | Rational Modification of the Biological Profile of GPCR Ligands through Combination with Other Biologically Active Moieties |
| Q90564100 | Selective Activation of Cannabinoid Receptor 2 Attenuates Myocardial Infarction via Suppressing NLRP3 Inflammasome |
| Q33623423 | The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory. |
| Q36413385 | Traditional herbal management of sickle cell anemia: lessons from Nigeria |
| Q52890709 | ω-Imidazolyl- and ω-Tetrazolylalkylcarbamates as Inhibitors of Fatty Acid Amide Hydrolase: Biological Activity and in vitro Metabolic Stability. |
Search more.